Skip to main content
Atrás
Watch Compare

BIOMERICA INC

Calidad de datos: 100%
BMRA
NASDAQ Manufacturing Chemicals
$2.08
▼ $0.06 (-2.80%)
Cap. Mercado: 6.49 M
6 months return
—
Momentum
Neutral
5Y revenue growth
-7.32%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue declined -7.32% annually over 5 years
Negative free cash flow of -2.99 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.40%
Capital efficient — spends only 0.54% of revenue on capex

Price History

Crecimiento

Revenue Growth (5Y)
-7.32%
Below sector avg (1.72%)
Revenue (1Y)-1.92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-83.94%
Below sector avg (-54.44%)
ROIC-86.66%
Net Margin-90.31%
Op. Margin-118.08%

Seguridad

Debt / Equity
N/A
Current Ratio3.25
Interest CoverageN/A

Valoración

PE (TTM|NTM)
-1.61 | 5.46
Below sector avg (-1.49)
P/B Ratio1.46
EV/EBITDAN/A
Dividend YieldN/A

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1385 pares)
Métrica Acción Mediana del Sector
P/E -1.6 -1.5
P/B 1.5 1.6
ROE % -83.9 -54.4
Net Margin % -90.3 -41.5
Rev Growth 5Y % -7.3 1.7
D/E — 0.3

Precio Objetivo de Analistas

Consenso de analistas: objetivo medio vs precio actual y calificación.

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Pronósticos de EPS e ingresos por período. Anual = años fiscales; trimestral = próximos trimestres.

No hay estimaciones futuras disponibles

Sorpresas de Ganancias

Último 1 trimestre
Trimestre EPS Est. EPS Real Sorpresa
Q12023 — -$0.96 —

All Fundamental Metrics
Growth
Revenue Growth (1Y) -1.92% Revenue Growth (3Y) -0.26%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -7.32% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.46 M Net Income (TTM) -4.03 M
ROE -83.94% ROA -62.46%
Gross Margin 5.63% Operating Margin -118.08%
Net Margin -90.31% Free Cash Flow (TTM) -2.99 M
ROIC -86.66% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.25
Interest Coverage N/A Asset Turnover 0.69
Working Capital 3.59 M Tangible Book Value 4.22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.61 Forward P/E 5.46
P/B Ratio 1.46 P/S Ratio 1.46
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield 18.32%
FCF Yield -46.05%
Market Cap 6.49 M Enterprise Value 3.95 M
Per Share
EPS (Diluted TTM) -2.51 Revenue / Share 1.48
FCF / Share -0.99 OCF / Share -0.98
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.54% FCF Conversion 74.26%
SBC-Adj. FCF -3.44 M Growth Momentum 5.40

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.31 M 5.42 M 5.34 M 18.87 M 7.20 M
Net Income -4.97 M -5.98 M -7.14 M -4.53 M -6.47 M
EPS (Diluted) -2.16 -0.36 -0.50 -0.36 -0.54
Gross Profit 498,000.0 611,000.0 446,000.0 2.98 M 496,981.0
Operating Income -5.14 M -6.37 M -7.22 M -4.53 M -6.52 M
EBITDA — — — — —
R&D Expenses 1.02 M 1.49 M 1.58 M 1.81 M 2.41 M
SG&A Expenses 4.61 M 5.49 M 6.09 M 5.70 M 4.61 M
D&A 87,000.0 81,000.0 84,000.0 100,000.0 104,715.0
Interest Expense — — — 367.0 367.0
Income Tax 1,000.0 42,000.0 51,000.0 23,719.0 13,057.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.95 M 9.25 M 14.45 M 11.37 M 11.82 M
Total Liabilities 1.84 M 2.66 M 2.73 M 3.05 M 2.59 M
Shareholders' Equity 4.11 M 6.59 M 11.72 M 8.32 M 9.23 M
Total Debt — — — — —
Cash & Equivalents 2.40 M 4.17 M 9.72 M 5.92 M 4.20 M
Current Assets 4.88 M 7.73 M 12.80 M 9.43 M 9.23 M
Current Liabilities 1.74 M 2.20 M 1.95 M 2.01 M 1.30 M